Park, W.; Han, J.H.; Wei, S.; Yang, E.-S.; Cheon, S.-Y.; Bae, S.-J.; Ryu, D.; Chung, H.-S.; Ha, K.-T.
Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. Int. J. Mol. Sci. 2024, 25, 807.
https://doi.org/10.3390/ijms25020807
AMA Style
Park W, Han JH, Wei S, Yang E-S, Cheon S-Y, Bae S-J, Ryu D, Chung H-S, Ha K-T.
Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. International Journal of Molecular Sciences. 2024; 25(2):807.
https://doi.org/10.3390/ijms25020807
Chicago/Turabian Style
Park, Wonyoung, Jung Ho Han, Shibo Wei, Eun-Sun Yang, Se-Yun Cheon, Sung-Jin Bae, Dongryeol Ryu, Hwan-Suck Chung, and Ki-Tae Ha.
2024. "Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer" International Journal of Molecular Sciences 25, no. 2: 807.
https://doi.org/10.3390/ijms25020807
APA Style
Park, W., Han, J. H., Wei, S., Yang, E.-S., Cheon, S.-Y., Bae, S.-J., Ryu, D., Chung, H.-S., & Ha, K.-T.
(2024). Natural Product-Based Glycolysis Inhibitors as a Therapeutic Strategy for Epidermal Growth Factor Receptor–Tyrosine Kinase Inhibitor-Resistant Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, 25(2), 807.
https://doi.org/10.3390/ijms25020807
